FTC Tells Medtronic To Sell Intersect ENT Subsidiary To Avoid Monopoly

[Editor's Note: On 30 June, the US Federal Trade Commission approved a final orderresolving the antitrust issues raised in Medtronic's acquisition of Intersect. Hemostasis closed the acquisition of Fiagon on 13 May.]

Medtronic plc has agreed to sell Fiagon AG, a subsidiary of Intersect ENT that makes ear, nose,...